MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT
, , , , , , , , , , , , , , and | Jun 07, 2024
About this article
Article Category: Original Article
Published Online: Jun 07, 2024
Page range: -
Received: Feb 20, 2024
Accepted: May 13, 2024
DOI: https://doi.org/10.2478/aite-2024-0012
Keywords
© 2024 Jagoda Siemaszko et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Jagoda Siemaszko
Laboratory of Clinical Immunogenetics and Pharmacogenetics,
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Wroclaw, Poland
Marta Dratwa
Laboratory of Clinical Immunogenetics and Pharmacogenetics,
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Wroclaw, Poland
Agnieszka Szeremet
Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation,
Wroclaw Medical UniversityWroclaw, Poland
Maciej Majcherek
Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation,
Wroclaw Medical UniversityWroclaw, Poland
Anna Czyż
Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation,
Wroclaw Medical UniversityWroclaw, Poland
Małgorzata Sobczyk-Kruszelnicka
Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of OncologyGliwice, Poland
Wojciech Fidyk
Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of OncologyGliwice, Poland
Iwona Solarska
Institute of Hematology and Blood Transfusion MedicineWarsaw, Poland
Barbara Nasiłowska-Adamska
Institute of Hematology and Blood Transfusion MedicineWarsaw, Poland
Patrycja Skowrońska
University Medical Center in Gdansk,
Gdansk, Poland
Maria Bieniaszewska
Department of Hematology and Transplantology,
Medical University of GdanskGdansk, Poland
Agnieszka Tomaszewska
Department of Hematology, Transplantation and Internal Medicine,
Medical University of WarsawWarsaw, Poland
Grzegorz W. Basak
Department of Hematology, Transplantation and Internal Medicine,
Medical University of WarsawWarsaw, Poland
Sebastian Giebel
Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of OncologyGliwice, Poland
Tomasz Wróbel
Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation,
Wroclaw Medical UniversityWroclaw, Poland
Katarzyna Bogunia-Kubik
Laboratory of Clinical Immunogenetics and Pharmacogenetics,
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Wroclaw, Poland